Orgenesis Inc (ORGS)

Orgenesis Inc (ORGS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.4M; returns 1 day +0.0%.

Orgenesis Inc. is a global biotechnology company specializing in the decentralization of cell and gene therapies (CGTs) through its proprietary Point of Care (POCare) platform. The company operates through two primary segments: Octomera (formerly Morgenesis) and Therapies.

Groups ORGS belongs to

• Biotechnology
• Gene Therapy
• Healthcare
• Autologous Cell Therapy
• Clinical Stage Biotech
• Contract Development and Manufacturing Organizations (CDMO)
• Life Sciences
• Immunotherapy
• Oncology
• Regenerative Medicine

ORGS financial model: income statement, cash flow and balance sheet